Therefore, we initially attempted to generate mice with a targeted NF45 disruption in the pancreatic β cells (β NF45−/− mice) to ascertain whether the NF90–NF45 downregulation in the pancreatic β cells is correlated with the occurrence of Type 2 diabetes. The gene discussed is ILF2; the disease is type 2 diabetes mellitus.